Chang Ho Ahn
Directeur/Bestuurslid bij TheraTarget, Inc.
Actieve functies van Chang Ho Ahn
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
TheraTarget, Inc.
 TheraTarget, Inc. Pharmaceuticals: MajorHealth Technology TheraTarget, Inc. develops innovative polymer therapeutics for the treatment of cancer. It is a biopharmaceutical drug delivery company developing a variety of polymer-drug conjugates utilizing our nanopolymer drug delivery technologies. The company was founded in October 2008 and is headquartered in Salt Lake, UT. | Directeur/Bestuurslid | - | - |
Loopbaan van Chang Ho Ahn
Eerdere bekende functies van Chang Ho Ahn
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| REXAHN PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 22-06-2015 | 31-08-2017 |
| Voorzitter | 01-05-2005 | 22-06-2015 | |
| Hoofd Techniek/Wetenschap/O&O | 08-03-2011 | - | |
| Oprichter | 19-03-2001 | 31-08-2017 | |
| President | 01-05-2005 | 05-02-2013 | |
| Rexahn Corp. | Algemeen Directeur | 01-03-2001 | 01-05-2005 |
| Voorzitter | 01-03-2001 | 01-05-2005 | |
| The Society of Biomedical Research | President | 01-01-2000 | 01-01-2003 |
| Center for Drug Evaluation & Research | Corporate Officer/Principal | 01-01-1988 | 01-01-2001 |
Opleiding van Chang Ho Ahn
| Creighton University | Undergraduate Degree |
| The Ohio State University | Doctorate Degree |
| Seoul National University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 8 |
| Zuid-Korea | 2 |
Operationeel
| Director/Board Member | 2 |
| Chairman | 2 |
| President | 2 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 3 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
| Rexahn Corp. | Finance |
Rexahn Pharmaceuticals, Inc.
 Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD. | Health Technology |
| The Society of Biomedical Research | |
| Center for Drug Evaluation & Research | Government |
TheraTarget, Inc.
TheraTarget, Inc. Pharmaceuticals: MajorHealth Technology TheraTarget, Inc. develops innovative polymer therapeutics for the treatment of cancer. It is a biopharmaceutical drug delivery company developing a variety of polymer-drug conjugates utilizing our nanopolymer drug delivery technologies. The company was founded in October 2008 and is headquartered in Salt Lake, UT. | Health Technology |
- Beurs
- Insiders
- Chang Ho Ahn
- Ervaring
